Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy

Bibliographic Details
Main Author: Shatavisa Mukherjee
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:MGM Journal of Medical Sciences
Online Access:http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=2;spage=258;epage=259;aulast=Mukherjee
_version_ 1818509354938138624
author Shatavisa Mukherjee
author_facet Shatavisa Mukherjee
author_sort Shatavisa Mukherjee
collection DOAJ
first_indexed 2024-12-10T22:44:25Z
format Article
id doaj.art-94de15db20a3498298baf1d4a9b284df
institution Directory Open Access Journal
issn 2347-7946
2347-7962
language English
last_indexed 2024-12-10T22:44:25Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series MGM Journal of Medical Sciences
spelling doaj.art-94de15db20a3498298baf1d4a9b284df2022-12-22T01:30:38ZengWolters Kluwer Medknow PublicationsMGM Journal of Medical Sciences2347-79462347-79622022-01-019225825910.4103/mgmj.mgmj_102_21Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapyShatavisa Mukherjeehttp://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=2;spage=258;epage=259;aulast=Mukherjee
spellingShingle Shatavisa Mukherjee
Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
MGM Journal of Medical Sciences
title Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
title_full Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
title_fullStr Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
title_full_unstemmed Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
title_short Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy
title_sort pyrazinamide induced morbilliform rash cutaneous complications in anti tubercular therapy
url http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=2;spage=258;epage=259;aulast=Mukherjee
work_keys_str_mv AT shatavisamukherjee pyrazinamideinducedmorbilliformrashcutaneouscomplicationsinantituberculartherapy